What is the first step in therapy for a woman who develops a ureterovaginal fistula 14 days after a hysterectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The first step in therapy for a woman who develops a ureterovaginal fistula 14 days after a hysterectomy is to initially manage the patient with ureteral stent placement when possible, as this approach has reported success rates of 64%-100% in resolving the fistula without the need for further surgical intervention. This recommendation is based on the latest guidelines from the American Urological Association, as outlined in the 2020 urotrauma guideline 1. The use of ureteral stent placement is supported by evidence showing that it can effectively divert urine away from the fistula site, allowing the injured ureter to heal.

Key considerations in the management of ureterovaginal fistula include:

  • Initial assessment to determine the feasibility of ureteral stent placement
  • Performance of the stent placement procedure by a urologist under fluoroscopic guidance
  • Maintenance of the diversion for 4-6 weeks to allow the fistula to heal spontaneously
  • Monitoring for signs of infection, obstruction, or persistent leakage during the diversion period

As noted in the guideline statement, if stent placement fails, additional surgical intervention, such as ureteral reimplantation, may be pursued 1. However, the initial approach with ureteral stent placement is preferred due to its less invasive nature and potential for high success rates in resolving the ureterovaginal fistula.

From the Research

Ureterovaginal Fistula Therapy

The first step in therapy for a woman who develops a ureterovaginal fistula 14 days after a hysterectomy involves:

  • Conservative management with ureteral stenting, as this approach has been shown to be successful in treating ureterovaginal fistulas in a significant number of cases 2
  • Ureteral stenting is considered first-line therapy for posthysterectomy ureterovaginal fistulas, with high cure rates reported in carefully selected patients 2
  • The stent is typically left in place for an average of 66 days, although the duration may vary depending on the individual case 2

Indications for Surgical Intervention

Surgical intervention, such as ureteroneocystostomy, may be necessary in cases where:

  • Conservative management with ureteral stenting fails 3, 2
  • There are complications, such as pyelonephritis or stricture, associated with ureteral stenting 2
  • The patient has a concurrent vesicovaginal fistula or a history of ureteral injury with surgical repair during the index surgery 2

Surgical Approaches

Various surgical approaches can be used to repair ureterovaginal fistulas, including:

  • Robotic-assisted ureteroneocystostomy, which provides a minimally invasive option for managing complex ureterovaginal fistulas 3
  • Open or laparoscopic abdominal approaches, which are also effective in repairing ureterovaginal fistulas 2, 4
  • Vaginal approach, which may be suitable for selected cases, providing a minimally invasive option for managing ureterovaginal fistulas 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Approach to Ureterovaginal Fistula: Examining 13 Years of Experience.

Female pelvic medicine & reconstructive surgery, 2019

Research

Robotic-assisted ureterovaginal fistula repair: report of efficacy and feasiblity.

Journal of laparoendoscopic & advanced surgical techniques. Part A, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.